105 -5 (79) 2025 - Maxmudov J.K. - EVALUATION OF ANTIBACTERIAL DRUGS IN PATIENTS WITH PURULENT-INFLAMMATORY DISEASES OF THE MAXILLOFACIAL REGION

EVALUATION OF ANTIBACTERIAL DRUGS IN PATIENTS WITH PURULENT-INFLAMMATORY DISEASES OF THE MAXILLOFACIAL REGION

Maxmudov J.K. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

Insufficient infiltration of the antibiotic in the inflammatory zone, combined with pathogen resistance and local tissue hypoxia, increases the likelihood of infectious complications and ineffectiveness of drug treatment, even if protocols for the rational administration of antibacterial therapy are followed

Keywords: microvasculature, purulent-inflammatory diseases, maxillofacial area, antibacterial therapy, blood rheology, gentamicin, vanco¬mycin

First page

527

Last page

530

For citation:Maxmudov J.K. - EVALUATION OF ANTIBACTERIAL DRUGS IN PATIENTS WITH PURULENT-INFLAMMATORY DISEASES OF THE MAXILLOFACIAL REGION//New Day in Medicine 5(79)2025 527-530 https://newdayworldmedicine.com/en/new_day_medicine/5-79-2025

List of References

1. Ahmed H, Bergmann F, Zeitlinger M. Protein Binding in Translational An¬timicrobial Development — Focus on Interspecies Differences. Antibiotics. 2022;11(7).-Р.923.
2. Neumann E, Tarner IH. Entzundung im Blut — was steckt dahinter? [In¬flammation in the blood: what’s behind it?]. Inn Med(Heidelb). 2023;64(4).-Р.304-312.
3. Миранович С.И., Петровский Е.В. Особенности антибактериальной терапии при лечении флегмон челюстно-лицевой области. Современ¬ная стоматология. 2013;1.-С.84-86.
4. Кабанова А.А. Резистентность к антибиотикам основных возбудите¬лей инфекционно-воспалительных заболеваний челюстно-лицевой области, выявленная в стационарах областных центров Республики Беларусь. Журнал Гродненского государственного медицинского универ¬ситета. 2017;2.-С.186-190.

   file

   download